TriangleHEALTH PROFESSIONAL · SOURCE READING
Treatment of Ciliary Body Melanoma
Source: Intraocular (Uveal) Melanoma Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 16, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Melanoma involving the ciliary body is rare and patients have a poor prognosis. In some cases, diagnosis may be difficult because of similarity to other eye diseases. The differential diagnosis of ciliary body melanoma is considered in cases of unilateral pigmentary glaucoma and chronic uveitis.[1]
Source links and citations
Ultrasound biomicroscopy can be used to evaluate tumor shape, thickness, margins, reflectivity, and local invasion.[2,3] Patients with tumors greater than 7 mm in thickness are at increased risk of metastatic disease and melanoma-related death compared with patients with thinner tumors.[4]
Continue within this section
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice